Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...
Gilero, a medical device manufacturer with two sites in North Carolina, is expanding to a third site in the state -- a new 60 ...
The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
The initiation of this Phase 3 program follows the announcement in June 2024 of the successful outcome of MoonLake's ...
Research and development expenses increased to $17.0 million for the three months ended September 30, 2024 from $15.4 million for the three months ended September 30, 2023 primarily due to ...